Analysis
European competition threatens AbbVie’s run of top-selling Humira
US pharma giant AbbVie Inc (ABBV) cut its overseas sales forecast on Friday for its offering Humira, on...
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
1,807 articles
Analysis
Earnings Preview: Strength in offerings will drive growth for CVS Health
CVS Health Corporation (CVS) is scheduled to report earnings results for the third quarter of 2018 on Tuesday,...
Analysis
Earnings preview: Mixed sentiment ahead of US Foods Holding’s Q3 report
Foodservice distributor US Foods Holding (USFD) is all set to announce results for the most recent quarter, after...
Analysis
Preview: Market bullish ahead of Booking Q3 earnings
Booking Holdings (BKNG) is scheduled to report third-quarter earnings on Monday, November 5. Analysts expect the travel giant...
Analysis
Motorola Solutions Q3 profit beats estimates
Motorola Solutions (MSI) reported a 16.5% jump in earnings for the third quarter as growth in the Americas...
Analysis
Facebook versus Twitter: How did each one do?
Social media companies Twitter (TWTR) and Facebook (FB) reported their third-quarter 2018 results on October 25 and 30,...
ADVERTISEMENT
Analysis
Starbucks stock surges after Q4 results make an impressive brew
Starbucks (SBUX), which exhibited weak sales in the US for last few quarters, posted consolidated net revenues of...
Analysis
Earnings: Spotify swings to profit in Q3, but investors irked by topline miss
Spotify (SPOT) defied Wall Street expectations of a loss in Q3 by posting a profit of €0.23 ($0.26)...
Analysis
There are way too many ‘zombie’ homes in America: Report
American cities are too busy, and one might think people really don’t have enough space to live. However,...
Analysis
Earnings preview: Not many reasons to hate Alibaba
Chinese retail giant Alibaba (BABA) has had a tough run this year, with the stock tumbling 35% from...
Analysis
Facebook (FB) posts slow revenue growth, but stock climbs on Q3 earnings beat
Facebook (FB) reported better-than-expected third quarter earnings of $1.76 per share, despite a considerable increase in expenses. Analysts...
Analysis
Earnings Preview: It’s a mixed bag for Teva Pharma in Q3
Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to post its third-quarter 2018 earnings on Nov 1, before the...